Long COVID headache.
Coronavirus disease-19
Diagnosis
Headache
Migraine
Morbidity
Pain
SARS-CoV-2
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
01 Aug 2022
01 Aug 2022
Historique:
received:
28
05
2022
accepted:
28
06
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
4
8
2022
Statut:
epublish
Résumé
Headache is among the most frequent symptoms persisting or newly developing after coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The knowledge on long COVID headache is still limited, however growing evidence is defining the features of this novel condition, in particular regarding clinical characteristics, some pathophysiological mechanisms and first treatment recommendations. Long COVID headache can present in the form of worsening of a preexisting primary headache, or, more specifically, in the form of a new (intermittent or daily) headache starting during the acute infection or after a delay. It often presents together with other long COVID symptoms, most frequently with hyposmia. It can manifest with a migrainous or, more frequently, with a tension-type-like phenotype. Persistent activation of the immune system and trigeminovascular activation are thought to play a role. As there are virtually no treatment studies, treatment currently is largely guided by the existing guidelines for primary headaches with the corresponding phenotype. The present report, a collaborative work of the international group of the Junior Editorial Board of The Journal of Headache and Pain aims to summarize the most recent evidence about long COVID headache and suggests approaches to the diagnosis and treatment of this disorder.
Identifiants
pubmed: 35915417
doi: 10.1186/s10194-022-01450-8
pii: 10.1186/s10194-022-01450-8
pmc: PMC9340759
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Informations de copyright
© 2022. The Author(s).
Références
J Neurol Sci. 2020 Jul 15;414:116884
pubmed: 32464367
Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1571-8
pubmed: 11009443
Lancet Respir Med. 2021 Nov;9(11):1328-1341
pubmed: 34678213
BMJ Open. 2017 Aug 11;7(8):e016670
pubmed: 28801425
Phys Ther. 2021 Jun 1;101(6):
pubmed: 33735380
Cephalalgia. 2020 Nov;40(13):1410-1421
pubmed: 33146036
Cephalalgia. 2014 Feb;34(2):93-102
pubmed: 23921798
Neurol Sci. 2021 Oct;42(10):3965-3968
pubmed: 34264414
Cephalalgia. 2020 Nov;40(13):1406-1409
pubmed: 33146034
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Nucl Med Mol Imaging. 2022 Feb;56(1):29-41
pubmed: 35069924
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3187-3197
pubmed: 33677642
Cephalalgia. 2021 Nov;41(13):1332-1341
pubmed: 34134526
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
Curr Pain Headache Rep. 2021 Nov 11;25(11):73
pubmed: 34766205
Eur J Neurol. 2021 Oct;28(10):3426-3436
pubmed: 33417287
Neurol Sci. 2021 May;42(5):1665-1673
pubmed: 33559789
Eur J Neurol. 2020 Mar;27(3):536-541
pubmed: 31574197
Cephalalgia. 2022 Jul;42(8):804-809
pubmed: 35166156
Int J Environ Res Public Health. 2022 Feb 06;19(3):
pubmed: 35162857
Ann Med. 2017 Mar;49(2):93-105
pubmed: 27560467
Int J Environ Res Public Health. 2021 Mar 05;18(5):
pubmed: 33807869
BJGP Open. 2020 Dec 15;4(5):
pubmed: 33051223
Respiration. 2022;101(2):122-131
pubmed: 34515247
J Headache Pain. 2013 Feb 01;14:9
pubmed: 23565964
Lancet Respir Med. 2021 Feb;9(2):129
pubmed: 33453162
Eur J Neurol. 2010 Nov;17(11):1318-25
pubmed: 20482606
Acta Neurol Belg. 2022 Apr;122(2):465-469
pubmed: 34546559
J Headache Pain. 2020 Jul 29;21(1):94
pubmed: 32727345
SN Compr Clin Med. 2021;3(8):1704-1706
pubmed: 34036244
J Headache Pain. 2021 Sep 7;22(Suppl 1):103
pubmed: 34488620
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5561-5577
pubmed: 34533807
J R Soc Med. 2021 Sep;114(9):428-442
pubmed: 34265229
Cephalalgia. 2020 Nov;40(13):1432-1442
pubmed: 33146037
Cephalalgia. 2002 Feb;22(1):66-9
pubmed: 11993616
Nature. 2022 Apr;604(7907):697-707
pubmed: 35255491
Ther Adv Chronic Dis. 2022 Feb 17;13:20406223221076890
pubmed: 35198136
Ther Adv Infect Dis. 2021 Apr 20;8:20499361211009385
pubmed: 33959278
Pharmacol Ther. 2018 Jun;186:88-97
pubmed: 29352859
J Headache Pain. 2021 Jun 4;22(1):51
pubmed: 34088273
J Headache Pain. 2017 Sep 25;18(1):96
pubmed: 28948500
SN Compr Clin Med. 2020;2(12):2509-2510
pubmed: 33263101
Lancet Respir Med. 2022 Jul;10(7):632-634
pubmed: 35525253
Front Hum Neurosci. 2021 Jun 28;15:678472
pubmed: 34295230
Int J Environ Res Public Health. 2022 Mar 26;19(7):
pubmed: 35409644
Brain Sci. 2022 Jan 24;12(2):
pubmed: 35203918
Open Forum Infect Dis. 2020 Jun 30;7(7):ofaa271
pubmed: 33117855
Headache. 2021 Sep;61(8):1277-1280
pubmed: 34363619
Front Neurol. 2020 Dec 17;11:583870
pubmed: 33391152
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2823-2833
pubmed: 33501506
Headache. 2020 Nov;60(10):2176-2191
pubmed: 32989732
Ann Intern Med. 2021 Sep;174(9):1252-1260
pubmed: 34224254
Front Cardiovasc Med. 2020 Oct 09;7:585866
pubmed: 33195473
Headache. 2020 Jul;60(7):1422-1426
pubmed: 32413158
Eur J Neurol. 2021 Nov;28(11):3820-3825
pubmed: 34327787
J Headache Pain. 2015;17:5
pubmed: 26857820
Headache. 2020 Sep;60(8):1797-1799
pubmed: 32790179
Headache. 2020 Jul;60(7):1415-1421
pubmed: 32412101
Clin Neuropharmacol. 2019 Jan/Feb;42(1):1-3
pubmed: 30499777
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
Cephalalgia. 2013 Jul;33(9):629-808
pubmed: 23771276
J Headache Pain. 2020 Oct 13;21(1):121
pubmed: 33050880
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
J Headache Pain. 2021 Aug 12;22(1):94
pubmed: 34384355
BMJ. 2021 Dec 16;375:n3103
pubmed: 34916215
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
J Clin Med. 2022 Jan 29;11(3):
pubmed: 35160182
J Headache Pain. 2010 Feb;11(1):59-66
pubmed: 19936615
Headache. 2015 Jan;55(1):3-20
pubmed: 25600718
Pediatr Neurol. 2014 Feb;50(2):135-9
pubmed: 24268688